Compare MobilEye Global Inc (MBLY) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? MobilEye Global Inc trades at $7.32 (market cap $6.08B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $13 (market cap $10.61B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while MobilEye Global Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| MBLY | RDY | |
|---|---|---|
Market Cap | $6.08B | $10.61B |
Volume | 9,825,806 | 3,738,869 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.33 | $15.38 |
52-Week Low | $6.56 | $11.38 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | $4.64B | $10.51B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.245, up 3.21% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong revenue growth to $1.89B in 2025 but posted a significant net loss of -$392M, with profitability metrics remaining negative. Recent news highlights ADAS business momentum and strategic investments in autonomous mobility, while analyst consensus leans positive with 57.7% buy ratings.
The stock presents a high-risk opportunity with substantial losses offset by strong revenue growth and market leadership in ADAS. Key catalysts include Porsche launch execution and robotaxi expansion, but investors face execution risks and persistent negative margins. The consensus price target of $10.77 suggests 49% upside potential from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
